Skip to main content

Table 6 Demographic and clinical characteristics of <5 years old children with uncomplicated falciparum malaria enrolled in study of the kinetics of the disposition of drug-attributable falls in haematocrit following artemisinin-based combination treatments

From: Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials

 

Treatment

P value

 

AA (n = 138)

AL (n = 148)

DHP (n = 146)

ALL (n = 432)

Male/Female

78/60

74/74

82/64

234/198

0.45

Age (month)

 Mean (95% CI)

38.4 (35.6–41.2)

41 (38.5–43.6)

36.5 (33.6–39.2)

38.6 (37.1–40.2)

0.06

 Age ≤ 24 [%]

36 [26]

27 [18]

53 [36]

116 [27]

0.002

Duration of illness (day)

 Mean (95% CI)

3.6 (3.1–4.1)

3.6 (3.1–4.1)

3.4 (2.9–3.9)

3.5 (3.2–3.8)

0.79

Temperature (°C)

 Mean (95% CI)

37.9 (37.7–38.1)

37.9 (37.5–38.2)

37.8 (37.4–38.2)

37.9 (37.6–38.1)

0.76

No. with temperature

 > 37.4 °C [%]

94 [68]

104 [70]

95 [65]

293 [68]

0.63

 > 40 °C [%]

9 [6.5]

4 [3]

7 [5]

20 [5]

0.29

Haematocrit (%)

 Mean (95% CI)

31.8 (31–32.6)

31.9 (31.2–32.7)

32.3 (31.5–33)

32 (31.6–33.4)

0.67

 No. with haematocrit <30% [%]

44 [32]

40 [27]

34 [23]

114 [26]

0.54

Parasitaemia (μL−1)

 Geometric mean

17,737

22,202

20,767

20,210

0.36

 Range

2000–200,000

2004–200,000

2003–200,000

2000–200,000

 

No with parasitaemia

 > 100,000 [%]

90 [65]

102 [69]

99 [68]

291 [67]

0.84

 Gametocyte carriage [%]

12 [8.7]

7 [4.7]

11 [7.5]

30 [6.9]

0.38

Fever clearance time (day)

 Mean (95% CI)

1.1 (1.1–1.2)

1.3 (1.2–1.4)

1.2 (1.1–1.3)

1.2 (1.2–1.3)

0.07

Parasite positivity

 On day 1 [%]

75 [54]

98 [66]

81 [55]

254 [59]

0.07

 On day 3 [%]

2 [1.4]

3 [2]

2 [1.4]

9 [2.1]

0.66

Parasite clearance time (day)

 Mean (95% CI)

1.8 (1.6–1.9)

1.9 (1.8–2)

1.7 (1.6–1.8)

1.8 (1.7–1.9)

0.054

  1. AA artesunate-amodiaquine, AL artemether-lumefantrine, DHP dihydroartemisinin-piperaquine, CI confidence interval